Annual EBITDA
$589.48M$97.04M+19.71%
Summary
- Current Value
- As of today, AMRX annual EBITDA is $589.48M, up +19.71% on
- Historical Performance
- AMRX annual EBITDA is up +28.79% over the past 3 years, and up +182.39% over the past 5 years
- All-Time High Comparison
- AMRX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- AMRX annual EBITDA is +33.79% above its 3-year low of $440.61M reached on an earlier date
- Sector Comparison
- AMRX annual EBITDA is higher than 92.03% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $589.48M | +19.7% | +28.8% | +182.4% | +511.6% | |
| Quarterly EBITDA | $126.88M | -14.7% | +19.5% | +29.9% | -0.4% | |
| TTM EBITDA | $604.79M | +5.9% | +49.9% | +68.5% | +30.4% | |
| Price | $13.26 | +68.5% | +500.0% | +167.3% | – | |
| PE Ratio | 940.43 | – | – | +10000.0% | – | |
| Annual Revenue | $2.79B | +16.7% | +33.5% | +71.8% | +679.5% | |
| Annual EPS | -$0.38 | +20.7% | -640.4% | +86.2% | -146.1% | |
| Annual EBIT | $353.29M | +34.3% | +57.5% | +10000.0% | +315.1% | |
| Annual Net Income | -$73.88M | -51.6% | -466.3% | +87.8% | -247.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $589.48M | at high | |
| 5Y | $589.48M | at high | |
| All | $589.48M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $440.61M | N/A | +33.8% |
| 5Y | $391.70M | N/A | +50.5% |
| All | -$19.67M | +3097.4% |
EBITDA History
FAQ
What is the current annual EBITDA of AMRX?
As of today, AMRX annual EBITDA is $589.48M
What is 1-year change in AMRX annual EBITDA?
AMRX annual EBITDA is up +19.71% year-over-year
What is 3-year change in AMRX annual EBITDA?
AMRX annual EBITDA is up +28.79% over the past 3 years
How far is AMRX annual EBITDA from its all-time high?
AMRX annual EBITDA is currently at its all-time high
How does AMRX annual EBITDA rank versus sector peers?
AMRX annual EBITDA is higher than 92.03% of companies in Healthcare sector
When is AMRX next annual earnings release?
The next annual earnings release for AMRX is on
Quarterly EBITDA
$126.88M$47.26M-27.14%
Summary
- Current Value
- As of today, AMRX quarterly EBITDA is $126.88M, down -27.14% on
- Historical Performance
- AMRX quarterly EBITDA is down -14.69% year-over-year, and up +19.47% over the past 3 years
- All-Time High Comparison
- AMRX quarterly EBITDA is currently -41.23% below its historical high of $215.91M set on
- 3-Year Low Comparison
- AMRX quarterly EBITDA is +32.79% above its 3-year low of $95.55M reached on
- Sector Comparison
- AMRX quarterly EBITDA is higher than 90.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $126.88M | -27.1% | -14.7% | +19.5% | +29.9% | |
| Annual EBITDA | $589.48M | – | +19.7% | +28.8% | +182.4% | |
| TTM EBITDA | $604.79M | -3.5% | +5.9% | +49.9% | +68.5% | |
| Price | $13.26 | +28.0% | +68.5% | +500.0% | +167.3% | |
| PE Ratio | 940.43 | +28.0% | – | – | +10000.0% | |
| Quarterly Revenue | $784.51M | +8.3% | +11.7% | +43.8% | +51.1% | |
| Quarterly EPS | $0.01 | -89.5% | +1560.0% | +141.0% | +112.0% | |
| Quarterly EBIT | $70.49M | -38.2% | -21.5% | +58.0% | +84.0% | |
| Quarterly Net Income | $18.13M | -49.1% | +54.2% | +858.7% | +182.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $174.14M | -27.1% | |
| 3Y | $174.14M | -27.1% | |
| 5Y | $174.14M | -27.1% | |
| All | $215.91M | -41.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $126.88M | at low | |
| 3Y | $95.55M | +32.8% | |
| 5Y | $80.92M | +56.8% | |
| All | -$13.85M | +1016.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of AMRX?
As of today, AMRX quarterly EBITDA is $126.88M
What is AMRX quarterly EBITDA most recent change?
AMRX quarterly EBITDA was down -27.14% on September 30, 2025
What is 1-year change in AMRX quarterly EBITDA?
AMRX quarterly EBITDA is down -14.69% year-over-year
How far is AMRX quarterly EBITDA from its all-time high?
AMRX quarterly EBITDA is currently -41.23% below its historical high of $215.91M set on March 1, 2010
How does AMRX quarterly EBITDA rank versus sector peers?
AMRX quarterly EBITDA is higher than 90.07% of companies in Healthcare sector
When is AMRX next earnings release?
The next earnings release for AMRX is on
TTM EBITDA
$604.79M$21.85M-3.49%
Summary
- Current Value
- As of today, AMRX TTM EBITDA is $604.79M, down -3.49% on
- Historical Performance
- AMRX TTM EBITDA is up +5.88% year-over-year, and up +49.93% over the past 3 years
- All-Time High Comparison
- AMRX TTM EBITDA is currently -3.49% below its historical high of $626.64M set on
- 3-Year Low Comparison
- AMRX TTM EBITDA is +36.81% above its 3-year low of $442.07M reached on an earlier date
- Sector Comparison
- AMRX TTM EBITDA is higher than 91.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $604.79M | -3.5% | +5.9% | +49.9% | +68.5% | |
| Annual EBITDA | $589.48M | – | +19.7% | +28.8% | +182.4% | |
| Quarterly EBITDA | $126.88M | -27.1% | -14.7% | +19.5% | +29.9% | |
| Price | $13.26 | +28.0% | +68.5% | +500.0% | +167.3% | |
| PE Ratio | 940.43 | +28.0% | – | – | +10000.0% | |
| TTM Revenue | $2.93B | +2.9% | +9.5% | +37.2% | +56.1% | |
| TTM EPS | $0.01 | +123.8% | +102.1% | +101.6% | -96.6% | |
| TTM EBIT | $361.99M | -5.1% | +5.2% | +122.0% | +180.2% | |
| TTM Net Income | $57.62M | +12.4% | +139.3% | +121.4% | +441.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $626.64M | -3.5% | |
| 3Y | $626.64M | -3.5% | |
| 5Y | $626.64M | -3.5% | |
| All | $626.64M | -3.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $589.48M | N/A | +2.6% |
| 3Y | $442.07M | N/A | +36.8% |
| 5Y | $371.22M | +62.9% | |
| All | -$20.82M | +3005.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of AMRX?
As of today, AMRX TTM EBITDA is $604.79M
What is AMRX TTM EBITDA most recent change?
AMRX TTM EBITDA was down -3.49% on September 30, 2025
What is 1-year change in AMRX TTM EBITDA?
AMRX TTM EBITDA is up +5.88% year-over-year
How far is AMRX TTM EBITDA from its all-time high?
AMRX TTM EBITDA is currently -3.49% below its historical high of $626.64M set on June 30, 2025
How does AMRX TTM EBITDA rank versus sector peers?
AMRX TTM EBITDA is higher than 91.25% of companies in Healthcare sector
When is AMRX next earnings release?
The next earnings release for AMRX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- AMRX Official Website www.amneal.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1723128/000172312825000059/0001723128-25-000059-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1723128/000172312825000012/0001723128-25-000012-index.htm
- AMRX Profile on Yahoo Finance finance.yahoo.com/quote/AMRX
- AMRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amrx